Filter
899
Filtered Results: 899
Text search:
General
Pharmaceutical
Council
Featured
Recommendations
67
New Publications
258
Language
Document type
No document type
509
Studies & Reports
169
Guidelines
115
Strategic & Response Plan
45
Manuals
28
Training Material
13
Fact sheets
10
Situation Updates
7
Resource Platforms
2
Brochures
1
Countries / Regions
India
56
Kenya
42
South Africa
34
Ethiopia
30
Nigeria
27
Global
24
Uganda
24
Western and Central Europe
21
Tanzania
20
Zambia
20
Sierra Leone
19
Nepal
17
Ghana
17
Zimbabwe
15
Bangladesh
14
Rwanda
13
Namibia
13
Ukraine
12
Malawi
12
Lesotho
10
Philippines
10
Africa
10
Liberia
9
Eastern Europe
8
Eswatini/ Swaziland
8
Syria
7
Cambodia
7
Myanmar / Burma
6
Latin America and the Carribbean
5
Botswana
5
Indonesia
5
South–East Asia Region
4
Eastern Europe and Central Asia
4
Pakistan
4
Guinea
3
Congo, Democratic Republic of
3
United Kingdom
3
East and Southern Africa
3
Thailand
2
Chile
2
Cameroon
2
Albania
2
Fiji
2
Burkina Faso
2
Peru
2
Mozambique
2
USA
2
Haiti
2
Asia
2
Jordan
2
Germany
2
West and Central Africa
2
Middle East and North Africa
2
Western Pacific Region
2
Jamaica
2
Lebanon
2
Brazil
2
Moldova
2
Egypt
2
Sudan
2
South Sudan
2
Timor Leste/ East Timor
1
El Salvador
1
Australia
1
Benin
1
China
1
Iran
1
Laos
1
Niger
1
Bulgaria
1
Venezuela
1
Lithuania
1
Ireland
1
Saudi Arabia
1
North America
1
Denmark
1
Maldives
1
Southern Africa
1
Russia
1
Yemen
1
Romania
1
Palestine
1
Central African Republic
1
Mali
1
Chad
1
Authors & Publishers
Publication Years
Category
Countries
441
Clinical Guidelines
45
Public Health
40
Key Resources
26
Women & Child Health
11
Pharmacy & Technologies
9
Capacity Building
5
Toolboxes
AMR
88
Pharmacy
75
COVID-19
63
Mental Health
56
HIV
43
TB
31
Global Health Education
21
Caregiver
20
NCDs
19
Conflict
19
Rapid Response
15
Health Financing Toolbox
15
Planetary Health
14
Specific Hazards
12
NTDs
9
Ebola
8
Refugee
6
Polio
5
Natural Hazards
3
Disability
3
Social Ethics
2
Cholera
1
Antimicrobial resistance (AMR) is a global threat that requires urgent
collaborative action within and among countries. As a result of the worldwide reports of the increasing rates of AMR to hospital and community-acquired infections and in the agricultural sector, the Global Action Plan on AMR was...
Glaucoma, a disease that gradually affects the optic nerve, is the second leading cause of vision loss globally, and it continues to pose a challenge to the eye health professionals.
The Ideal Clinic Realisation and Maintenance (ICRM) programme was initiated by the National Department of Health in July 2013 in order to systematically improve primary health care (PHC) facilities and the quality of care they provide. The Ideal Clinic framework/dashboard sets out the standards for ...
Antimicrobial resistance (AMR) is a multifaceted, international public health problem, which poses a direct threat to the safety of the population of South Africa. A national response is required to complement the development of a global plan, as articulated in the WHO’s draft resolution EB134/37 ...
Communication to Healthcare Professionals Mar-2020
This guideline is intended to assist healthcare professionals in the participation of very important process of continuous surveillance of safety and efficacy of the health products which are used in their clinical practice. Continuous evaluation o...
This document offers public health guidance for the prevention and control of COVID-19 in reception centres, and other temporary accommodation facilities, in the context of the mass influx of Ukrainian people into the European Union (EU), the European Economic Area (EEA) and the Republic of Moldova.
Lancet Planet Health 2020; 4: e271–79
Building on our decades of commitment to human rights in medicine and healthcare, we have published a new report on emerging threats in health-related human rights both globally and in the UK.
'Health and human rights in the new world (dis)order' outlines a shifting rights landscape in which new ...
After a decade of crisis, Syria remains one of the world’s most complex humanitarian crises. Continued hostilities, new and protracted displacement, increased returns and the sustained destruction of communities have impacted Syrians’ lives and futures in a devastating way. The 2021 Humanitarian...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards
the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized ...
Indian markets caused a stir across the country.1
According to the Centre for Science and the Environment (CSE), a respected New Delhi-based NGO, most honey brands
sold in India contained varying amounts of antibiotics. Their consumption over time could induce resistance to antibiotics,
putting p...
I examine the effectiveness of donors in targeting the highest burden of malaria in the Democratic Republic of Congo when health information structure is fragmented. I exploit local variations in the burden of malaria induced by mining activities as well as financial and epidemiological data from he...
Several challenges face asthma management in Egypt, including the high percentage of uncontrolled patients, inadequate compliance, and overuse of short-acting beta-agonists (SABAs) leading to increased asthma-related morbidity and mortality. In this regard, the recent Global Initiative for Asthma (G...
These guidelines provide evidence-based guidance on the use of peripartum antiviral prophylaxis in HBsAg-positive pregnant women for the prevention of mother-to-child transmission of HBV.
WHO six-year strategy for the health sector and community capacity development.
Provide guidance to HIV care practitioners on the optimal use of antiretroviral (ARV) agents for the treatment of HIV infection in adults and adolescents.
This version of Field Trials of Health Interventions includes seven new chapters on conducting systematic literature reviews, trial
governance, preliminary studies and pilot testing, budgeting and accounting, intervention costing and economic analysis, and Phase IV studies. Before new interventions...
